A detailed history of Israel Englander (Millennium Management LLC) transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Millennium Management LLC holds 230,079 shares of ANIP stock, worth $13.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
230,079
Previous 20,807 1005.78%
Holding current value
$13.4 Million
Previous $1.44 Million 918.85%
% of portfolio
0.01%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$58.53 - $68.82 $12.2 Million - $14.4 Million
209,272 Added 1005.78%
230,079 $14.7 Million
Q1 2024

May 15, 2024

SELL
$54.2 - $69.69 $80,920 - $104,047
-1,493 Reduced 6.7%
20,807 $1.44 Million
Q4 2023

Feb 14, 2024

BUY
$48.72 - $65.43 $603,835 - $810,939
12,394 Added 125.12%
22,300 $1.23 Million
Q2 2023

Aug 14, 2023

SELL
$37.29 - $53.83 $257,338 - $371,480
-6,901 Reduced 41.06%
9,906 $533,000
Q1 2023

May 15, 2023

SELL
$37.61 - $45.72 $369,593 - $449,290
-9,827 Reduced 36.9%
16,807 $668,000
Q4 2022

Feb 14, 2023

SELL
$31.9 - $41.95 $804,964 - $1.06 Million
-25,234 Reduced 48.65%
26,634 $1.07 Million
Q3 2022

Nov 14, 2022

BUY
$29.83 - $38.01 $433,549 - $552,437
14,534 Added 38.93%
51,868 $1.67 Million
Q2 2022

Aug 15, 2022

SELL
$23.09 - $33.46 $1.06 Million - $1.54 Million
-45,936 Reduced 55.17%
37,334 $1.11 Million
Q1 2022

May 16, 2022

BUY
$26.91 - $47.15 $2.24 Million - $3.93 Million
83,270 New
83,270 $2.34 Million
Q4 2021

Feb 14, 2022

SELL
$32.97 - $56.85 $233,295 - $402,270
-7,076 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$26.48 - $35.99 $187,372 - $254,665
7,076 New
7,076 $232,000
Q1 2021

May 17, 2021

SELL
$28.4 - $36.14 $657,516 - $836,713
-23,152 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$23.69 - $31.47 $548,470 - $728,593
23,152 New
23,152 $672,000
Q2 2020

Aug 14, 2020

SELL
$29.93 - $50.1 $517,938 - $866,980
-17,305 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$30.35 - $67.14 $525,206 - $1.16 Million
17,305 New
17,305 $705,000
Q2 2019

Aug 14, 2019

SELL
$67.77 - $82.2 $480,150 - $582,387
-7,085 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$45.83 - $70.54 $171,679 - $264,242
-3,746 Reduced 34.59%
7,085 $500,000
Q4 2018

Feb 14, 2019

SELL
$41.17 - $56.44 $92,508 - $126,820
-2,247 Reduced 17.18%
10,831 $488,000
Q3 2018

Nov 14, 2018

BUY
$52.95 - $71.34 $692,480 - $932,984
13,078 New
13,078 $739,000
Q2 2018

Aug 14, 2018

SELL
$56.38 - $68.08 $2.68 Million - $3.24 Million
-47,544 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$56.98 - $72.41 $2.52 Million - $3.21 Million
44,288 Added 1360.2%
47,544 $2.77 Million
Q4 2017

Feb 14, 2018

BUY
$53.3 - $74.56 $173,544 - $242,767
3,256
3,256 $210,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $1.02B
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.